Related Experiment Videos
Aortic valve replacement in the elderly: bioprosthesis or mechanical valve?
Y Logeais1, T Langanay, H Corbineau
1Service of Cardiovascular and Thoracic Surgery, University Hospital Center, Hôpital Pontchaillou, Rennes, France.
The Annals of Thoracic Surgery
|February 4, 1999
Summary
For elderly patients undergoing aortic valve replacement, bioprostheses show higher rates of structural deterioration and reoperation compared to mechanical valves, suggesting age-specific recommendations.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Geriatric Medicine
Background:
- Increasing life expectancy leads to more frequent valve surgeries in elderly patients.
- The selection between mechanical valves and bioprostheses for aortic valve replacement is a subject of ongoing debate.
- Elderly populations present unique challenges for prosthetic valve choice due to comorbidities and life expectancy.
Purpose of the Study:
- To compare the long-term outcomes of mechanical valves versus bioprostheses in elderly patients undergoing isolated aortic valve replacement.
- To evaluate differences in mortality, morbidity, and specific valve-related complications between the two prosthetic types.
- To provide evidence-based recommendations for prosthetic valve selection in the aging population.
Main Methods:
- A comparative study involving two groups of patients aged 69-71 years undergoing isolated aortic valve replacement.
- Group 1: 240 patients received mechanical valves.
- Group 2: 289 patients received bioprostheses. Outcomes assessed included survival, morbidity, and valve-related complications.
Main Results:
- No significant differences were observed in overall survival, valve-related mortality, infective endocarditis, or thromboembolism between mechanical and bioprosthetic valves.
- Mechanical valves were associated with a higher incidence of bleeding events.
- Bioprostheses demonstrated increased rates of structural deterioration, reoperation, and overall valve-related morbidity and mortality.
Conclusions:
- Bioprosthetic valve durability must be considered in relation to patient life expectancy to minimize reoperations in octogenarians.
- Current bioprosthetic valves may be best suited for patients with an expected lifespan of less than 10 years.
- Specific age recommendations suggest bioprostheses use after age 74 for men and 78 for women to align with projected longevity and reduce reoperation risk.